Legal Representation
Attorney
Danny M. Awdeh
USPTO Deadlines
Next Deadline
877 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-12-28)
Due Date
December 28, 2027
Grace Period Ends
June 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
48 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 28, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Feb 28, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Feb 28, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Feb 28, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Feb 28, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Dec 28, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 20, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Nov 19, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Nov 2, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Oct 29, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
Oct 29, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
May 8, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 7, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
May 7, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Apr 29, 2021 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Apr 29, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 30, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 28, 2020 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Oct 28, 2020 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Oct 28, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 28, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 24, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Apr 24, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Apr 24, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 23, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 21, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Oct 21, 2019 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Oct 21, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 19, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 17, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 17, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 17, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 17, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Apr 17, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Nov 13, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 18, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 18, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 29, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 16, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
Aug 6, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 6, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Aug 6, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 6, 2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 6, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jul 31, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 24, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Apr 21, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 16, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others
First Use Anywhere:
May 12, 2021
First Use in Commerce:
May 12, 2021
Additional Information
Design Mark
The mark consists of the word "CRINETICS" above the word "PHARMACEUTICALS" with a dot and line spirograph design in the shape of a half circle starting above the letter "I" in "CRINETICS" and wrapping around the first letter "C" in "CRINETICS".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"